Moss HA - Search Results

1

The Clinical Trial Conundrum for Gynecologic Cancers.

Havrilesky LJ, Moss HA. Havrilesky LJ, et al. Among authors: moss ha. Obstet Gynecol. 2023 Sep 1;142(3):457-458. doi: 10.1097/AOG.0000000000005307. Epub 2023 Aug 3. Obstet Gynecol. 2023. PMID: 37548377 No abstract available.

2

Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers.

Havrilesky LJ, Moss HA, Chino J, Myers ER, Kauff ND. Havrilesky LJ, et al. Among authors: moss ha. Gynecol Oncol. 2017 Jun;145(3):549-554. doi: 10.1016/j.ygyno.2017.03.025. Epub 2017 Apr 6. Gynecol Oncol. 2017. PMID: 28390820

3

Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act.

Moss HA, Havrilesky LJ, Chino J. Moss HA, et al. Gynecol Oncol. 2017 Sep;146(3):457-464. doi: 10.1016/j.ygyno.2017.06.012. Epub 2017 Jun 20. Gynecol Oncol. 2017. PMID: 28641821

4

Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?

Berchuck A, Secord AA, Moss HA, Havrilesky LJ. Berchuck A, et al. Among authors: moss ha. J Clin Oncol. 2017 Dec 20;35(36):3999-4002. doi: 10.1200/JCO.2017.74.5752. Epub 2017 Oct 26. J Clin Oncol. 2017. PMID: 29072978 No abstract available.

5

The use of patient-reported outcome tools in Gynecologic Oncology research, clinical practice, and value-based care.

Moss HA, Havrilesky LJ. Moss HA, et al. Gynecol Oncol. 2018 Jan;148(1):12-18. doi: 10.1016/j.ygyno.2017.11.011. Epub 2017 Nov 23. Gynecol Oncol. 2018. PMID: 29174565 Review.

6

Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.

Moss HA, Samimi G, Havrilesky LJ, Sherman ME, Myers ER. Moss HA, et al. Genet Epidemiol. 2018 Feb;42(1):117-122. doi: 10.1002/gepi.22095. Epub 2017 Nov 30. Genet Epidemiol. 2018. PMID: 29193313

7

Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Moss HA, Berchuck A, Neely ML, Myers ER, Havrilesky LJ. Moss HA, et al. JAMA Oncol. 2018 Feb 1;4(2):190-195. doi: 10.1001/jamaoncol.2017.4211. JAMA Oncol. 2018. PMID: 29222541 Free PMC article.

8

Health Care Disparities in Cancer Patients Receiving Radiation: Changes in Insurance Status After Medicaid Expansion Under the Affordable Care Act.

Chino F, Suneja G, Moss H, Zafar SY, Havrilesky L, Chino J. Chino F, et al. Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):9-20. doi: 10.1016/j.ijrobp.2017.12.006. Epub 2017 Dec 13. Int J Radiat Oncol Biol Phys. 2018. PMID: 29398128

9

Trends in Insurance Status Among Patients Diagnosed With Cancer Before and After Implementation of the Affordable Care Act.

Moss HA, Havrilesky LJ, Zafar SY, Suneja G, Chino J. Moss HA, et al. J Oncol Pract. 2018 Feb;14(2):e92-e102. doi: 10.1200/JOP.2017.027102. J Oncol Pract. 2018. PMID: 29436303

10

Hysterectomy with sentinel lymph node biopsy in the setting of pre-operative diagnosis of endometrial intraepithelial neoplasia: A cost-effectiveness analysis.

Lim SL, Moss HA, Secord AA, Lee PS, Havrilesky LJ, Davidson BA. Lim SL, et al. Among authors: moss ha. Gynecol Oncol. 2018 Dec;151(3):506-512. doi: 10.1016/j.ygyno.2018.09.020. Epub 2018 Sep 23. Gynecol Oncol. 2018. PMID: 30257786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters